Skip to main content
. 2019 Jul 24;4(10):1401–1411. doi: 10.1016/j.ekir.2019.07.009

Table 4.

Diagnostic performance of candidate markers in distinguishing CKDu, ECKD, and NECKD from NEC

Parameter AUC (95% CI) % (95% CI)
P value
Sensitivity Specificity
CKDu vs. NEC
 A1M 0.914 (0.863–0.966) 92.0 (83.2–96.5) 84.7 (75.4–90.9) <0.0001
 B2M 0.696 (0.604–0.787) 53.3 (42.2–64.2) 92.9 (85.1–97.0) <0.0001
 CST3 0.817 (0.749–0.885) 69.3 (58.1–78.6) 84.7 (75.4–90.9) <0.0001
 NGAL 0.827 (0.759–0.894) 82.7 (72.4–89.7) 72.9 (62.6–81.2) <0.0001
 OPN 0.585 (0.486–0.684) 44.0 (33.3–55.3) 84.7 (75.4–90.9) 0.093
 RBP4 0.735 (0.650–0.819) 81.3 (70.9–88.6) 63.5 (52.9–73.0) <0.0001
 KIM1 0.520 (0.422–0.617) 38.7 (28.5–50.0) 72.9 (62.6–81.2) 0.694
 TIMP1 0.620 (0.527–0.713) 40.0 (29.7–51.3) 84.7 (75.4–90.9) 0.011
ECKD vs. NEC
 A1M 0.913 (0.867–0.959) 87.8 (78.7–93.4) 84.7 (75.4–90.9) <0.0001
 B2M 0.832 (0.763–0.901) 74.4 (63.9–82.6) 89.4 (80.8–94.5) <0.0001
 CST3 0.843 (0.779–0.906) 72.0 (61.3–80.5) 90.6 (82.2–95.3) <0.0001
 NGAL 0.797 (0.728–0.865) 75.6 (65.2–83.6) 75.3 (65.1–83.3) <0.0001
 OPN 0.756 (0.681–0.832) 48.8 (38.3–59.4) 95.3 (88.0–98.5) <0.0001
 RBP4 0.804 (0.731–0.877) 85.4 (75.9–91.5) 74.1 (63.8–82.3) <0.0001
 KIM1 0.684 (0.602–0.766) 80.5 (70.5–87.7) 50.6 (40.2–60.9) <0.0001
 TIMP1 0.738 (0.664–0.813) 54.9 (44.1–65.2) 84.7 (75.4–90.9) <0.0001
NECKD vs. NEC
 A1M 0.891 (0.843–0.938) 77.6 (67.6–85.2) 91.8 (83.6–96.2) <0.0001
 B2M 0.852 (0.795–0.909) 77.6 (67.6–85.2) 82.4 (72.7–89.1) <0.0001
 CST3 0.851 (0.791–0.910) 70.6 (60.1–79.2) 90.6 (82.2–95.3) <0.0001
 NGAL 0.767 (0.697–0.837) 69.4 (58.9–78.2) 75.3 (65.1–83.3) <0.0001
 OPN 0.586 (0.499–0.674) 54.1 (43.6–64.3) 69.4 (58.9–78.2) 0.053
 RBP4 0.862 (0.805–0.919) 91.8 (83.6–96.2) 76.5 (66.3–84.2) <0.0001
 KIM1 0.716 (0.639–0.792) 78.8 (68.9–86.2) 55.3 (44.7–65.4) <0.0001
 TIMP1 0.747 (0.674–0.820) 55.3 (44.7–65.4) 84.7 (75.4–90.9) <0.0001

A1M, alpha 1 microglobulin; AUC, area under the curve; B2M, beta 2 microglobulin; CI, confidence interval; CKDu, chronic kidney disease of uncertain etiology; CST3, cystatin C; ECKD, endemic chronic kidney disease; KIM1, kidney injury molecule 1; NEC, nonendemic control; NECKD, nonendemic chronic kidney disease; NGAL, neutrophil gelatinase-associated lipocalin; OPN, osteopontin; RBP4, retinol binding protein 4; TIMP1, tissue inhibitor of metalloproteinase 1.